CN1364088A - 治疗神经变性疾病的il6ril6嵌合物 - Google Patents
治疗神经变性疾病的il6ril6嵌合物 Download PDFInfo
- Publication number
- CN1364088A CN1364088A CN00808910A CN00808910A CN1364088A CN 1364088 A CN1364088 A CN 1364088A CN 00808910 A CN00808910 A CN 00808910A CN 00808910 A CN00808910 A CN 00808910A CN 1364088 A CN1364088 A CN 1364088A
- Authority
- CN
- China
- Prior art keywords
- cell
- block polymer
- il6ril6
- myelin
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL130586 | 1999-06-21 | ||
IL13058699A IL130586A0 (en) | 1999-06-21 | 1999-06-21 | IL6RIL6 chimera for the treatment of demyelinating diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1364088A true CN1364088A (zh) | 2002-08-14 |
CN1164328C CN1164328C (zh) | 2004-09-01 |
Family
ID=11072949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008089108A Expired - Fee Related CN1164328C (zh) | 1999-06-21 | 2000-06-21 | 治疗神经变性疾病的il6ril6嵌合物 |
Country Status (21)
Country | Link |
---|---|
US (1) | US7201896B1 (zh) |
EP (1) | EP1185293B1 (zh) |
JP (1) | JP4846148B2 (zh) |
KR (1) | KR100678290B1 (zh) |
CN (1) | CN1164328C (zh) |
AT (1) | ATE306280T1 (zh) |
AU (1) | AU778662B2 (zh) |
BR (1) | BR0011363A (zh) |
CA (1) | CA2374997C (zh) |
DE (1) | DE60023139T2 (zh) |
DK (1) | DK1185293T3 (zh) |
EA (1) | EA004626B1 (zh) |
EE (1) | EE05559B1 (zh) |
ES (1) | ES2250140T3 (zh) |
HK (1) | HK1047549A1 (zh) |
IL (2) | IL130586A0 (zh) |
MX (1) | MXPA02000116A (zh) |
NO (1) | NO329028B1 (zh) |
UA (1) | UA76695C2 (zh) |
WO (1) | WO2000078331A2 (zh) |
ZA (1) | ZA200109488B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5030364B2 (ja) | 2000-09-14 | 2012-09-19 | アレス トレーディング ソシエテ アノニム | ハンチントン病におけるil−6r/il−6キメラの使用 |
DE10107737A1 (de) * | 2001-02-16 | 2002-09-05 | S Rose John Christian Albrecht | Verwendung eines Konjugats aus IL-6 und einem IL-6 Rezeptor zur Tumortherapie |
JP4594588B2 (ja) * | 2001-04-10 | 2010-12-08 | ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ | 抗体特異的プロファイルの治療的および診断的使用方法 |
IL147412A0 (en) * | 2001-12-31 | 2002-08-14 | Yeda Res & Dev | The use of il6r/il6 chimera in nerve cell regeneration |
CA2527847C (en) | 2003-06-12 | 2015-09-29 | Yeda Research & Development Co. Ltd | Enhancement of oligodendrocyte differentiation |
EP1692273A1 (en) * | 2003-11-14 | 2006-08-23 | Mats J. Olsson | Melanocytes in therapy of neurodegenerative diseases |
IL161672A0 (en) | 2004-04-29 | 2004-09-27 | Yeda Res & Dev | Compositions and methods for therapy of chemotherapy-induced neuropathy |
IL163856A0 (en) * | 2004-09-01 | 2005-12-18 | Applied Research Systems | Use of IL-6 in vascular complications |
US20170231558A1 (en) * | 2016-02-12 | 2017-08-17 | Als Therapy Development Institute | Measurement Of ALS Progression Based On Kinetic Data |
WO2018056412A1 (ja) * | 2016-09-23 | 2018-03-29 | 国立大学法人大阪大学 | シュワン細胞分化促進剤及び末梢神経再生促進剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL122818A0 (en) * | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
JPH1148413A (ja) | 1997-08-06 | 1999-02-23 | Dainippon Printing Co Ltd | ホルムアルデヒド捕捉壁紙およびその製造方法 |
JP4859153B2 (ja) * | 1999-02-25 | 2012-01-25 | 東ソー株式会社 | 新規神経系細胞分化促進剤 |
-
1999
- 1999-06-21 IL IL13058699A patent/IL130586A0/xx unknown
-
2000
- 2000-06-21 AT AT00939022T patent/ATE306280T1/de active
- 2000-06-21 MX MXPA02000116A patent/MXPA02000116A/es active IP Right Grant
- 2000-06-21 ES ES00939022T patent/ES2250140T3/es not_active Expired - Lifetime
- 2000-06-21 CA CA2374997A patent/CA2374997C/en not_active Expired - Fee Related
- 2000-06-21 DE DE60023139T patent/DE60023139T2/de not_active Expired - Lifetime
- 2000-06-21 US US09/980,823 patent/US7201896B1/en not_active Expired - Fee Related
- 2000-06-21 BR BR0011363-8A patent/BR0011363A/pt not_active Application Discontinuation
- 2000-06-21 WO PCT/IL2000/000363 patent/WO2000078331A2/en active IP Right Grant
- 2000-06-21 JP JP2001504394A patent/JP4846148B2/ja not_active Expired - Fee Related
- 2000-06-21 CN CNB008089108A patent/CN1164328C/zh not_active Expired - Fee Related
- 2000-06-21 KR KR1020017015303A patent/KR100678290B1/ko not_active IP Right Cessation
- 2000-06-21 UA UA2002010458A patent/UA76695C2/uk unknown
- 2000-06-21 DK DK00939022T patent/DK1185293T3/da active
- 2000-06-21 EE EEP200100689A patent/EE05559B1/xx not_active IP Right Cessation
- 2000-06-21 AU AU54231/00A patent/AU778662B2/en not_active Ceased
- 2000-06-21 EP EP00939022A patent/EP1185293B1/en not_active Expired - Lifetime
- 2000-06-21 EA EA200200063A patent/EA004626B1/ru not_active IP Right Cessation
-
2001
- 2001-11-16 ZA ZA200109488A patent/ZA200109488B/xx unknown
- 2001-11-20 NO NO20015673A patent/NO329028B1/no not_active IP Right Cessation
- 2001-12-19 IL IL147188A patent/IL147188A/en not_active IP Right Cessation
-
2002
- 2002-12-19 HK HK02109201A patent/HK1047549A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EE200100689A (et) | 2003-02-17 |
KR20020013901A (ko) | 2002-02-21 |
WO2000078331A2 (en) | 2000-12-28 |
KR100678290B1 (ko) | 2007-02-05 |
EE05559B1 (et) | 2012-08-15 |
WO2000078331A3 (en) | 2001-07-05 |
BR0011363A (pt) | 2002-02-26 |
AU778662B2 (en) | 2004-12-16 |
ZA200109488B (en) | 2002-11-18 |
ATE306280T1 (de) | 2005-10-15 |
UA76695C2 (uk) | 2006-09-15 |
US7201896B1 (en) | 2007-04-10 |
EA200200063A1 (ru) | 2002-06-27 |
MXPA02000116A (es) | 2003-07-21 |
HK1047549A1 (en) | 2003-02-28 |
DK1185293T3 (da) | 2005-12-27 |
EP1185293A2 (en) | 2002-03-13 |
ES2250140T3 (es) | 2006-04-16 |
EP1185293B1 (en) | 2005-10-12 |
EA004626B1 (ru) | 2004-06-24 |
JP2003502382A (ja) | 2003-01-21 |
AU5423100A (en) | 2001-01-09 |
JP4846148B2 (ja) | 2011-12-28 |
CA2374997A1 (en) | 2000-12-28 |
IL147188A (en) | 2015-09-24 |
CN1164328C (zh) | 2004-09-01 |
NO329028B1 (no) | 2010-08-02 |
NO20015673D0 (no) | 2001-11-20 |
IL130586A0 (en) | 2000-06-01 |
NO20015673L (no) | 2001-12-17 |
CA2374997C (en) | 2010-04-13 |
DE60023139T2 (de) | 2006-05-04 |
DE60023139D1 (de) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11020456B2 (en) | Methods for modulating an inflammatory response | |
Kadi et al. | Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro | |
JP5294635B2 (ja) | コポリマー1と組み合わせた、神経発生の誘発及び幹細胞治療 | |
Kang et al. | Loss of neuron-astroglial interaction rapidly induces protective CNTF expression after stroke in mice | |
CN1164328C (zh) | 治疗神经变性疾病的il6ril6嵌合物 | |
CN1452492A (zh) | 神经保护肽 | |
JP2010509235A (ja) | 多発性硬化症の治療 | |
CN1812800A (zh) | 用于促进和增强神经修复和再生的肌肉来源的细胞(mdc) | |
SK38998A3 (en) | Truncated glial cell line-derived neurotrophic factor | |
Liang et al. | Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control | |
Martinez‐Serrano et al. | Ex vivo gene transfer of brain‐derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons | |
CN111989404A (zh) | 表达脑源性神经营养因子的间充质干细胞及其用途 | |
Haggiag et al. | Induction of myelin gene expression in Schwann cell cultures by an interleukin-6 receptor-interleukin-6 chimera | |
WO2023030489A1 (zh) | 经基因改造的少突胶质祖细胞在多发性硬化症中的应用 | |
CN1073264A (zh) | 基于组织的特定的nt-3表达与受体结合的治疗和诊断方法 | |
Jana et al. | Induction of IL-2 by interleukin-12 p40 homodimer and IL-12, but not IL-23, in microglia and macrophages: Implications for multiple sclerosis | |
WO2004069177A2 (en) | Methods for modulating an inflammatory response | |
JPWO2008093827A1 (ja) | 中枢神経障害治療剤及び中枢神経障害の治療方法 | |
WO1996034619A1 (en) | Methods of preventing neuron degeneration and promoting neuron regeneration | |
Tregs Regulatory | Mahdieh Yousefi1, Abolghasem Nabipour, Mazdak Ganjalikhani Hakemi2, Mehnoosh Ashja‑Arvan2, Noushin Amirpour3 & Hossein Salehi3Ε | |
Penna | UNDERSTANDING AND PROMOTING THE FUNCTIONAL INTEGRATION OF NEURAL TRANSPLANTS IN PARKINSON’S | |
Gonzalez | CXCL10 plays a critical role in secondary degeneration following spinal cord injury | |
Spooren | Regulation of IL-6 expression in astrocytes | |
Zullo | BATF transgenic mice: Investigating the role of AP-1 in the development and function of natural killer T lymphocytes | |
Luo et al. | Inhibition of Chondroitin Sulfate Proteoglycan Interactions With Receptor PTPσ Promotes Neurogenesis and Recovery From Stroke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1047549 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: SERONO LAB Free format text: FORMER OWNER: APPLIED RESEARCH SYSTEMS ARS HOLDING N. V. Owner name: MERCK SERONO S. A. Free format text: FORMER OWNER: SERONO LAB |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110201 Address after: Voight, Israel Co-patentee after: Merck Serono S.A. Patentee after: YEDA RESEARCH AND DEVELOPMENT CO.,LTD. Address before: Voight, Israel Co-patentee before: LABORATOIRES SERONO S.A. Patentee before: YEDA RESEARCH AND DEVELOPMENT CO.,LTD. Effective date of registration: 20110201 Address after: Voight, Israel Co-patentee after: LABORATOIRES SERONO S.A. Patentee after: YEDA RESEARCH AND DEVELOPMENT CO.,LTD. Address before: Voight, Israel Co-patentee before: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. Patentee before: YEDA RESEARCH AND DEVELOPMENT CO.,LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040901 Termination date: 20160621 |